Search - tctmd.com

Displaying 21 - 35 of 35

Sort: Relevancy | Date

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

L.A. McKeown

November 29, 2018

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Daily News

CMS Reverses Its Course on Bundled Payments for MI, CABG

Caitlin E. Cox

August 16, 2017

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After ACS Saves Money, Prevents Bleeding

News Conference News EuroPCR 2017

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS

Yael L. Maxwell

May 16, 2017

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Shelley Wood

May 05, 2017

News Conference News AHA 2016

Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance

L.A. McKeown

November 23, 2016

News Daily News

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Todd Neale

March 01, 2016

News Daily News

Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge

Caitlin E. Cox

February 16, 2016

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

June 08, 2015

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

Advertisement

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

CMS Reverses Its Course on Bundled Payments for MI, CABG

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content